5 research outputs found
Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas
Background: Leiomyomas growth involves cellular hypertrophy, modulation
of mitotic activity and upregulation of extracellular matrix (ECM).
Vascular factors and matrix metalloproteinases (MMPs) play a coordinated
role during neoplasia and tissue remodeling. The present study
investigates the role of angiogenic factor vascular endothelial growth
factor (VEGF)-A with the activity of main gelatinases, MMP-2/MMP-9 and
their tissue inhibitor TIMP-1 in patients with leiomyomas.
Methods: Peripheral blood of 46 women with uterine leiomyomas was
obtained prior hysterectomy to assess VEGF-A, MMP-2, -9, TIMP-1 levels
by enzyme-linked immunosorbent assay compared to 39 healthy controls.
Protein expression levels of VEGF-A, MMP-2 and MMP-9 were evaluated by
western immunoblotting and immunohistochemistry in leiomyomas tissue
specimens after hysterectomy. Furthermore, the activity of gelatinases
in leiomyoma tissue extracts and control myometrium was evaluated by
semi-quantitative zymography.
Results: Circulating levels of VEGF-A, MMP-2 and TIMP-1 were
significantly elevated in leiomyoma patients compared to controls (p <
0.001, p = 0.004, p = 0.003, respectively). A positive correlation was
found between VEGF-A and MMP-2 (p = 0.021) as well as MMP-9 (p = 0.001)
peripheral levels in the patient's group. Furthermore, increased VEGF-A
protein levels were detected in leiomyoma tissue compared to control
myometrium, followed by increased localization of both VEGF-A and MMP-2
in the ECM embedding bundles of smooth muscle cells of leiomyomas. The
activity of MMP-2 was significantly higher in leiomyomas than normal
myometrium in all investigated tissues.
Conclusions: This study demonstrates a possible coordinated role of
VEGF-A and MMP-2 during uterine leiomyomas growth and angiogenesis with
potential prognostic significance
MicroRNAs: Novel Diagnostic and Prognostic Biomarkers in Atherosclerosis
MicroRNAs (miRNAs) are an emerging class of highly conserved, non-coding
small RNAs that regulate gene expression on the post-transcriptional
level by inhibiting the translation of protein from mRNA or by promoting
the degradation of mRNA. The involvement of miRNAs in the regulation of
lipid metabolism, inflammatory response, cell cycle progression and
proliferation, oxidative stress, platelet activation, endothelial
function, angiogenesis and plaque formation and rapture indicates
important roles in the initiation and progression of atherosclerosis. In
the light of this evidence we will review the role of miRNAs in
atherosclerosis
Association of Sarcoidosis With Endothelial Function, Arterial Wall Properties, and Biomarkers of Inflammation
BACKGROUND
Sarcoidosis is an inflammatory disease, which may affect vascular
function. The study was designed to assess the impact of sarcoidosis on
endothelial function and arterial stiffness.
METHODS
Eighty-seven sarcoidosis patients and eighty-seven matched healthy
subjects (CI) were included in the study. Sarcoidosis patients were
divided into two groups. Group 1 included patients never treated and
group 2 included patients receiving cortisone treatment. Endothelial
function was evaluated by flow-mediated dilatation (FMD).
Carotid-femoral pulse wave velocity (PWV) was measured as an index of
aortic stiffness and augmentation index (A175) as a measure of arterial
wave reflections. Serum levels of soluble intercellular adhesion
molecule-1 and tumor necrosis factor-alpha (TNF-alpha), were measured.
RESULTS
In the totality of the population, sarcoidosis patients had
significantly lower FMD (P < 0.01) and significantly higher A175 (P <
0.05). There was also a significant difference, between group 1, and Cl
in FMD and A175, but there was no difference between group 2 and CI in
FMD and A175. A175 values were significantly correlated with serum
levels of intercellular adhesion molecule-1 (ICAM-1) (r = 0.370, P <
0.01) and TNF-alpha (r = 0.219, P = 0.049).
CONCLUSIONS
In the present study, we have shown that sarcoidosis patients have
impaired endothelial function and increased arterial stiffness.
Sarcoidosis patients on cortisone treatment had no differences compared
to controls on the vascular parameters. Moreover, there was a
significant correlation between inflammatory process and vascular
function impairment. These findings indicate that sarcoidosis patients
have impaired vascular function and increased inflammatory status, which
may improve with cortisone treatment